MARKET

ANNX

ANNX

Annexon, Inc.
NASDAQ
4.655
+0.165
+3.67%
Opening 13:30 12/05 EST
OPEN
4.500
PREV CLOSE
4.490
HIGH
4.740
LOW
4.500
VOLUME
1.16M
TURNOVER
--
52 WEEK HIGH
5.66
52 WEEK LOW
1.285
MARKET CAP
676.19M
P/E (TTM)
-3.3511
1D
5D
1M
3M
1Y
5Y
1D
Independent Director of Annexon Jung Choi Buys More Stock
Simply Wall St · 16h ago
Director Makes Bold Move with Major Stock Purchase in Annexon Biosciences!
TipRanks · 2d ago
Annexon Director William H. Carson Reports Acquisition of Common Shares
Reuters · 2d ago
Annexon Director Jung Choi Acquires Common Shares
Reuters · 2d ago
Annexon Price Target Announced at $17.00/Share by Clear Street
Dow Jones · 3d ago
Annexon Initiated at Buy by Clear Street
Dow Jones · 3d ago
Clear Street Initiates Coverage On Annexon with Buy Rating, Announces Price Target of $17
Benzinga · 3d ago
Annexon initiated with a Buy at Clear Street
TipRanks · 4d ago
More
About ANNX
Annexon, Inc. is a clinical-stage biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye. It identifies and characterizes the role of the classical complement pathway in three therapeutic areas: autoimmune, neurodegeneration and ophthalmology, using its proprietary platform. Its lead candidate, ANX005, an investigational, full-length monoclonal antibody (mAb), is formulated for intravenous administration as the potential first targeted treatment for patients with Guillain-Barre Syndrome (GBS). It is advancing ANX1502, a novel small-molecule inhibitor of classical complement designed for oral administration in a range of chronic autoimmune diseases. It is also advancing ANX007, designed to block C1q locally in the eye, to provide complete protection against excess classical complement activity and the loss of photoreceptor neurons.

Webull offers Annexon Inc stock information, including NASDAQ: ANNX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANNX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANNX stock methods without spending real money on the virtual paper trading platform.